4119 — SCI Pharmtech Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Annual income statement for SCI Pharmtech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,356	2,689	864	900	1,204
Cost of Revenue
Gross Profit	936	1,274	208	291	350
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	1,659	1,638	791	781	1,044
Operating Profit	697	1,052	73.7	119	160
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	711	455	65.5	388	364
Provision for Income Taxes
Net Income After Taxes	571	360	55.7	309	295
Net Income Before Extraordinary Items
Net Income	571	360	55.7	309	295
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	571	360	55.7	309	295
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.18	3.26	0.508	2.82	2.69
Dividends per Share